Abstract:Diverse bacterial and fungal microbiota communities inhabit the human body, and their presence is essential for maintaining host homeostasis. The oral cavity, lung, gut, and vagina are just a few of the bodily cavities where these microorganisms communicate with one another, either directly or indirectly. The effects of this interaction can be either useful or detrimental to the host. When the healthy microbial diversity is disturbed, for instance, as a result of prolonged treatment with broad spectrum antibiotics, this allows the growth of specific microbes at the expense of others and alters their pathogenicity, causing a switch of commensal germs into pathogenic germs, which could promote tissue invasion and damage, as occurs in immunocompromised patients. Consequently, antimicrobials that specifically target pathogens may help in minimizing secondary issues that result from the disruption of useful bacterial/fungal interactions (BFIs). The interface between Candida albicans and Aspergillus fumigatus with bacteria at various body sites is emphasized in the majority of the medically important BFIs that have been reported thus far. This interface either supports or inhibits growth, or it enhances or blocks the generation of virulence factors. The aim of this review is to draw attention to the link between the bacterial and fungal microbiota and how they contribute to both normal homeostasis and disease development. Additionally, recent research that has studied microbiota as novel antimicrobials is summarized.

mSphere of Influence: the Mycobiota in Human Health and Disease

The Human Mucosal Mycobiome and Fungal Community Interactions

Frontiers in Human Mycobiome in Health and Disease

A Human Commensal-Pathogenic Fungus Suppresses Host Immunity Via Targeting TBK1

Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis

New focus on microecology: intestinal fungi

Human mycobiome and diseases

Microbiota Regulation of Inflammatory Bowel Disease and Colorectal Cancer

The mycobiota of the human body: a spark can start a prairie fire

The Gut Mycobiome in Health, Disease, and Clinical Applications in Association with the Gut Bacterial Microbiome Assembly.

Bacteria-derived short-chain fatty acids as potential regulators of fungal commensalism and pathogenesis

Fungal‐induced Glycolysis in Macrophages Promotes Colon Cancer by Enhancing Innate Lymphoid Cell Secretion of IL‐22

Cross interaction between bacterial and fungal microbiota and their relevance to human health and disease: mechanistic pathways and prospective therapy

Editorial: New insights into the role of mycobiome in diseases.

The Human Microbiota in Health and Disease

The mycobiome as integral part of the gut microbiome: crucial role of symbiotic fungi in health and disease

Mucosal Immunity to Gut Fungi in Health and Inflammatory Bowel Disease

Fungal Influence on Immune Cells and Inflammatory Responses in the Tumor Microenvironment (Review)

Bacterial‐fungal interactions and their impact on microbial pathogenesis

mSphere of Influence: How host genetics impact microbial pathogenesis and treatment of infectious disease

mSphere of Influence: Combining Host and Pathogen Genetics To Disrupt Chronic Infections